Profil
Albertien Greijdanus was the founder of Alleviant Medical, Inc. and held the title of Director & Chief Compliance Officer since its founding in 2017.
Ms. Greijdanus is currently a Senior Investment Manager at Brabantse Ontwikkelings Maatschappij Holding BV, starting in 2024.
Education includes an undergraduate degree from Delft University of Technology conferred in 2008 and a graduate degree conferred in 2011.
Postes actifs de Albertien Greijdanus
| Sociétés | Poste | Début |
|---|---|---|
Brabantse Ontwikkelings Maatschappij Holding BV
Brabantse Ontwikkelings Maatschappij Holding BV Investment ManagersFinance BOM invests in companies located across the globe, primarily in Netherlands. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Private Equity Investor | 01/01/2024 |
Anciens postes connus de Albertien Greijdanus
| Sociétés | Poste | Fin |
|---|---|---|
Alleviant Medical, Inc.
Alleviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a medical device company developing potential therapies for congestive heart failure | Fondateur | - |
Formation de Albertien Greijdanus
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Delft University of Technology
Delft University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brabantse Ontwikkelings Maatschappij Holding BV
Brabantse Ontwikkelings Maatschappij Holding BV Investment ManagersFinance BOM invests in companies located across the globe, primarily in Netherlands. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Alleviant Medical, Inc.
Alleviant Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a medical device company developing potential therapies for congestive heart failure | Commercial Services |
















